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AMINOGLYCOSIDE EFFECTS ON VOLTAGE-SENSITIVE 
CALCIUM CHANNELS AND NEUROTOXICITY 
To the Editor: Since ototoxicity and neuromuscular toxicity of 
. aminoglycoside antibiotics are reversed by calcium, 1.2 and presyn-
. aptie events appear to be involved in aminoglycoside-induced neu-I romuscular blockade,3.4 we suspected a role for voltage-sensitive 
calcium channels in aminoglycoside neurotoxicity. Among the sev-
rral subtypes of those channels, the N-channel is predominantly 
involved in neurotransmitter release.5.' We investigated the influ-
mees of therapeutic concentrations of aminoglycosides on N-chan-
nels monitored by either 45Ca2+ uptake or binding of the calcium-
channel toxin [125I)omega-conotoxin GV lA, which predominantly 
labels N-channels in neuronal membranes." 
Aminoglycosides inhibit brain neuronal and sympathetic-gan-
glia-membrane binding of [125I)conotoxin, and relative potencies 
correlate closely with neuromuscular toxicity (r = 0.69, P<0.02 for 
brain; r = 0.70, P<O.OI for ganglial (Table 1). By contrast, the 
aminoglycosides are much weaker or totally inactive at L-channels 
labeled with [3H)nitrendipine. Both the absolute and relative drug 
potencies are similar in blocking [125l)conotoxin binding and 
!lea2+ uptake into rat-brain synaptosomes under conditions 
,in which calcium accumulation selectively involves N-channels 
(r= 0.94, P<0.001).7 Aminoglycoside inhibition of 45Ca2+ up-
take also correlates well with neuromuscular toxicity (r = 0.71, 
P<O.OOI). Moreover, the drugs inhibit 45Ca2+ uptake and [1251) 
. conotoxin by 50 percent at therapeutic plasma and tissue con-
centrations.l,2 
Our data suggesting a role for N-type calcium channels in amino-
glycoside neurotoxicity are in accord with the reversal of toxic ef-
frets by calcium treatment. Other calcium-dependent events may 
~so be relevant, especially in renal toxicity, as is suggested by 
aminoglycoside inhibition of renal phosphatidylinositol phospho-
lipase.9 Ototoxicity derived from initial impairment of cochlear ac-
:tion potentials by aminoglycosides may reflect an influence on 
action potential-linked calcium channels, since early ototoxicity is 
reversed by calcium. 1,2 
We suggest that the screening of potential aminoglycoside antibi-
otics at N-channels may identify the agents that are less toxic. 
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: Table 1. Aminoglycoside Potencies at Calcium-Channel Binding Sites and Calcium 
, Flux through N-Channels. 
[ 3H)NITRENDIPINE [ 125IjCONOTOXIN [ 125IjCONOTOXIN 
BINDING TO BINDING TO 4SCa2+ BINDING TO 
PRESYNAPTIC BRAIN MEMBRANEst BRAIN MEMBRANES:t UPfAKE§ SYMPATHETIC GANGLIA+: 
WOOL YCOSIDE NEUROTOXICITY· (N = 12) (N = 11) (N = 17) (N = 11) 
median inhibitory concentration (JJ.M) 
, Neomycin ++++ >1000 3 5 7 
Amikacin +++ >1000 10 10 15 
Gentamicin ++ >1000 10 20 20 
Tobramycin ++ >1000 20 50 28 
Streptomycin ++ 330 50 150 60 
Kuuunycin + >1000 200 500 250 
-Presynaptic neuromuscular toxicity levels were derived from experimental studies. 3 
t[3H]Nitrendipine binding was assayed in whole rat-brain homogenates as previously described.6 Median inhibitory 
ao:entrations were derived from single experiments performed in duplicate and repeated twice. 
nl~]Omega-conotoxin binding was assayed in whole rat-brain homogenates and rabbit sympathetic-ganglion homoge-
IlCS as previously described. 8 Median inhibitory concentrations were derived from single experiments performed in dupli-
cat and repeated twice. 
iSynaptosomal 4SCa2+ flux was assayed as previously described. 7 Median inhibitory concentrations were derived from 
Uvidual experiments performed in triplicate and repeated three times and represent the concentration of drug inhibiting 
Ipnd binding by 50 percent. Correlations (see text) were computed from all repetitions of experiments. 
